Pashtoon Kasi: Our work on the use of BOT/BAL in the neoadjuvant setting for patients with advanced colon and rectal cancer

Quoting Pashtoon Kasi, Director of Colon Cancer Research at the Weill Cornell Medicine, on X/Twitter:

“Our work on the use of BOT/BAL in the neoadjuvant setting for patients with advanced colon and rectal cancer. Full open access version & visual abstract now available at Oncogene journal. Detailed results coming soon. Hope for this to become an option for our patients.”